当前位置:首页 - 行情中心 - 南模生物(688265) - 财务分析 - 现金流量表

南模生物

(688265)

  

流通市值:32.94亿  总市值:32.94亿
流通股本:7796.35万   总股本:7796.35万

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金310,480,271.4169,082,455.973,803,262.03429,553,758.31
  收到其他与经营活动有关的现金14,572,806.427,870,948.486,291,233.0612,441,880.73
  经营活动现金流入小计325,053,077.82176,953,404.3880,094,495.09441,995,639.04
  购买商品、接受劳务支付的现金104,333,838.2772,180,284.1331,386,970.5393,207,697.23
  支付给职工以及为职工支付的现金178,737,292.94111,811,803.7764,095,373.35170,778,214.54
  支付的各项税费1,802,388.841,427,947.91996,403.013,561,241.41
  支付其他与经营活动有关的现金68,153,837.0432,383,612.3218,993,698.7677,529,239.29
  经营活动现金流出小计353,027,357.09217,803,648.13115,472,445.65345,076,392.47
  经营活动产生的现金流量净额-27,974,279.27-40,850,243.75-35,377,950.5696,919,246.57
二、投资活动产生的现金流量:
  收回投资收到的现金1,379,288,264.911,051,492,778.59659,123,965.032,964,732,447.57
  取得投资收益收到的现金---45,827.72
  处置固定资产、无形资产和其他长期资产收回的现金净额31,693.8513,623.8513,623.8542,521.52
  投资活动现金流入小计1,379,319,958.761,051,506,402.44659,137,588.882,964,820,796.81
  购建固定资产、无形资产和其他长期资产支付的现金65,872,582.3540,807,570.6823,405,297.5845,611,357.46
  投资支付的现金1,318,000,000927,000,000427,000,0003,044,400,000
  投资活动现金流出小计1,383,872,582.35967,807,570.68450,405,297.583,090,011,357.46
  投资活动产生的现金流量净额-4,552,623.5983,698,831.76208,732,291.3-125,190,560.65
三、筹资活动产生的现金流量:
  取得借款收到的现金19,800,000---
  收到其他与筹资活动有关的现金33,427,749.834,204,886.4--
  筹资活动现金流入平衡项目00--
  筹资活动现金流入小计53,227,749.834,204,886.4--
  分配股利、利润或偿付利息支付的现金9,658,370.38---
  支付其他与筹资活动有关的现金13,608,097.089,833,077.483,645,586.1620,406,417.32
  筹资活动现金流出小计23,266,467.469,833,077.483,645,586.1620,406,417.32
  筹资活动产生的现金流量净额29,961,282.37-5,628,191.08-3,645,586.16-20,406,417.32
四、汇率变动对现金及现金等价物的影响-3,698,490.54-2,577,098.86-1,314,584.34-1,747,828.67
五、现金及现金等价物净增加额-6,264,111.0334,643,298.07168,394,170.24-50,425,560.07
  加:期初现金及现金等价物余额145,861,947.93145,789,285.53145,861,947.93196,214,845.6
  期末现金及现金等价物余额139,597,836.9180,432,583.6314,256,118.17145,789,285.53
补充资料:
  净利润-9,076,619.83-31,436,529.76
  资产减值准备-3,837,895.8-2,099,198.48
  固定资产和投资性房地产折旧-15,746,444.04-30,649,323.29
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-15,746,444.04-30,649,323.29
  无形资产摊销-3,741,743.37-7,453,406.88
  长期待摊费用摊销-6,939,959.33-16,347,834.36
  处置固定资产、无形资产和其他长期资产的损失----38,969.27
  固定资产报废损失-7,869-171,471.78
  公允价值变动损失--7,704,944.58--17,682,289.12
  财务费用-3,764,387.62-3,885,942.08
  投资损失--589,073.61--1,775,193.98
  递延所得税--1,225,213.86--2,341,263.19
  其中:递延所得税资产减少--1,327,615.55--1,858,180.38
    递延所得税负债增加-102,401.69--483,082.81
  存货的减少--18,844,202.38--8,144,990.77
  经营性应收项目的减少--69,213,937.96--14,705,115.34
  经营性应付项目的增加--3,438,642.32-28,354,234.26
  其他-5,261,111.75--6,017,825.75
  不涉及现金收支的投资和筹资活动金额其他项目-5,272,099.42-698,517.34
  现金的期末余额-180,432,583.6-145,789,285.53
  减:现金的期初余额-145,789,285.53-196,214,845.6
  现金及现金等价物的净增加额-34,643,298.07--50,425,560.07
公告日期2026-10-302026-08-292026-04-302026-04-27
审计意见(境内)标准无保留意见
TOP↑